We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

Microscopic image of a group of bacteria cells

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

A blue beetle.

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

Protein structures.

Scientists Uncover the Cellular Functions of Proteins Integral to Inflammatory Diseases

Common Antibiotic Shows Promise in the Treatment of Respiratory Viral Infections

Rice Bran Nanoparticles Show Promise as Anti-Cancer Agent

Study Investigates How Aspirin Helps To Prevent Colorectal Cancer Development

News

Galapagos Gives R&D Update

Competitive positioning and Phase II study plans in RA for GLPG0634.

4SC Discovery and CRELUX Enter into a Strategic Alliance

Strategic partnership for integrated drug discovery services.

OGT to Host Company Showcase at BioTrinity 2012

Seminar to discuss company’s biomarker accelerator strategy for optimizing drug and diagnostic development.

CTI Reports First Quarter Financial Results and Milestones

Entered into an agreement to acquire highly selective Phase 3 JAK2 inhibitor, pacritinib.

Rockland Immunochemicals and LDI Form Antibody Commercialization Partnership

Rockland will market LDI’s entire portfolio of LIMR monoclonal and polyclonal antibodies.

Idenix Pharmaceuticals Provides Update on Hepatitis C Clinical Development Programs

Company announced data from a phase I clinical trial of IDX719, an NS5A inhibitor for the treatment of hepatitis C virus (HCV) infection, demonstrating potent pan-genotypic antiviral activity with single doses.

Baxter Announces Biologics Capacity Expansion

Plan includes new manufacturing site in Georgia and creation of more than 2,000 U.S. jobs.

Genzyme's Biologics Support Center Achieves LEED Gold Rating for Environmentally Responsible Design

Site is Genzyme's tenth LEED-certified Green Building.

Pharmatek Increases Liquid Filled Capsule Capacity

Addition of new technology increases Company’s rate and scale of liquid fill productions.

CTI Enters into Agreement to Acquire Pacritinib

Reported lack of blood and platelet side effects provides attractive regulatory and commercial profile over other JAK inhibitors.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter